Humankind Investments »

Apogee Therapeutics shares owned by Humankind Investments

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Humankind Investments from 13F filings

Historical chart of Humankind Investments investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Humankind Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Humankind Investments

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.5M 18k 84.17

More positions owned by Humankind Investments

Invesco Qqq Tr Unit Ser 1 (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Exch Traded Fd Tr Ii Solar Etf (TAN)
Ark Etf Tr Genomic Rev Etf (ARKG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ishares Tr Ishares Biotech (IBB)
Cisco Systems (CSCO)
Global X Fds U S Electrificat (ZAP)
Bristol Myers Squibb (BMY)
Pfizer (PFE)
Sony Group Corp Sponsored Adr (SONY)
Synopsys (SNPS)

View all positions for Humankind Investments

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Vanguard Capital Management
Henderson Group
Driehaus Capital Management
State Street Corporation
Perceptive Advisors
Paradigm Biocapital Advisors
Affinity Asset Advisors
Geode Capital Management

View all funds holding Apogee Therapeutics